MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 206 participants.
Also called NCT03545607
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 206 participants
- Sponsor
- Registry
-
NCT03545607
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Taiwan
- Registry status
- Terminated
Technical summary
Registry record NCT03545607. Randomized; quadruple masking; primary purpose treatment. Start 2018-07-28 (actual); primary completion 2024-10-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
- Acronym
- MASTERS-2
- Condition
- Ischemic Stroke
- Intervention (Biological)
- MultiStem
- Intervention (Biological)
- Placebo
- Lead sponsor
- Healios K.K.
- Collaborator
- Medpace, Inc.
Record details
- Record id
cardio:ct-nct03545607- Content hash
9e1031f5a0e2f655a7fadd903323a68f3f6eebcca54125b7243dbde192fa169c